Apixaban cut the rate of stroke by 50% in atrial fibrillation patients, according to data from the multinational AVERROES trial. The study concluded earlier than planned because of the astonishing results of the Apixaban.
In addition to the benefit, Apixaban also is does not increase the risk of bleeding or liver toxicity. Although not approved for market, the drug will be somewhat troublesome for patients as it requires two doses daily.
480.905.9208
Toll Free:
1.888.905.9208
February 6, 2012 Fibroids Associated with Higher Risk of Preterm Labor and Other Complications (2.6.12) A small study shows that women found with fibroids at their first ultrasound are at...
January 27, 2012 Proper Diet can Reduce Risk of Developing Diabetes in Childhood and Adulthood (1.27.12) Prior and recent studies demonstrate that a healthy diet and reduced body fat can reduce...
January 23, 2012 Tysabri (natalizumab) Associated with Progressive Multifocal Leukoencephalopathy (PML) (1.20.12) According to the FDA testing positive for anti-JC virus antibodies has been identified as a...
January 10, 2012 Women at Increased Risk of Diabetes From Statins (1.10.12) Recent data indicate that older women taking statins are at almost a 50% increased risk...
January 9, 2012 Leafy and Fruiting Vegetables Reduce Risk of Breast Cancer (1.9.12) Studies involving more than 31,000 women demonstrated that women consuming greater quantities of leafy and...
January 3, 2012 HPV Testing Best Indicator for Cervical Cancer for Women Over 30 (1.3.12) A large screening study involving 45,000 women has shown that HPV testing proved more effective...
Leave a comment